Jump Financial, LLC Annexon, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.49 - $7.2 $192,858 - $309,261	-42,953 Closed	0 $0
Q2 2024 Aug 14, 2024	SELL	$4.33 - $6.79 $724,179 - $1.14 Million	-167,247 Reduced 79.57%	42,953 $210,000
Q1 2024 May 13, 2024	BUY	$4.03 - $7.81 $847,106 - $1.64 Million	210,200 New	210,200 $1.51 Million
Q1 2023 Oct 21, 2024	SELL	$3.74 - $7.46 $43,335 - $86,439	-11,587 Reduced 26.98%	31,366 $120,000
Q1 2023 May 03, 2023	BUY	$3.74 - $7.46 $71,980 - $143,575	19,246 Added 158.8%	31,366 $120,000
Q4 2022 Feb 13, 2023	BUY	$4.56 - $6.61 $55,267 - $80,113	12,120 New	12,120 $62,000
Q2 2022 Aug 09, 2022	SELL	$2.11 - $4.06 $77,859 - $149,814	-36,900 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.73 - $11.94 $9,546 - $41,754	-3,497 Reduced 8.66%	36,900 $101,000
Q4 2021 Feb 10, 2022	BUY	$11.49 - $22.0 $464,161 - $888,734	40,397 New	40,397 $464,000

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $251M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.